Hearing disorders and hearing loss: Autifony Therapeutics has a new approach to treating hearing disorders and is now recruiting for clinical trials

Autifony Drug Development

Autifony has two clinical stage programmes: one for hearing disorders (AUT00063) and one for schizophrenia (AUT00206). Treatments for other serious CNS diseases are also at earlier stages of exploration.

See our Pipeline page and News sections for more.